Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson S Meng

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Advanced Drug Delivery Reviews|December 12, 2018
Advances in immunotherapy of type I diabetesQianqian Ni, Ngoc B Pham, Wilson S Meng, et al.
American Journal of Pharmaceutical Education|January 17, 2017
A Bioinformatics Practicum to Develop Student Understanding of Immunological Rejection of Protein DrugsLauren A O'Donnell, Wilson S Meng, Benjamin J Andrick, et al.
Journal of Biomaterials Science. Polymer Edition|January 31, 2007
Characterization of particles fabricated with poly(D, L-lactic-co-glycolic acid) and an ornithine-histidine peptide as carriers of oligodeoxynucleotide for delivery into primary dendritic cellsYing Zheng, Jeffrey R Kovacs, Ellen S Gawalt, et al.
Clinical Immunology (Orlando, Fla.)|March 17, 2015
Generation of antigen-specific Foxp3+ regulatory T-cells in vivo following administration of diabetes-reversing tolerogenic microspheres does not require provision of antigen in the formulationCarl Engman, Yi Wen, Wilson S Meng, et al.
Molecular Immunology|October 18, 2003
A cationic peptide consists of ornithine and histidine repeats augments gene transfer in dendritic cellsSai Prasanth Chamarthy, Jeffrey R Kovacs, Erin McClelland, et al.
Plos One|August 14, 2015
Predicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNFα Biologics: Implications for Immunogenicity of Pharmaceutical ProteinsBenjamin J Andrick, Alexandra I Schwab, Brianna Cauley, et al.
Fluids (Basel, Switzerland)|June 24, 2026
Evaluation of Flow-Induced Shear in a Porous Microfluidic Slide: CFD Analysis and Experimental InvestigationManoela Neves, Gayathri Aparnasai Reddy, Anitha Niyingenera, et al.
Biomaterials|December 19, 2007
Expansion of Foxp3-expressing regulatory T cells in vitro by dendritic cells modified with polymeric particles carrying a plasmid encoding interleukin-10Liang Jia, Jeffrey R Kovacs, Ying Zheng, et al.
Urologic Oncology|May 14, 2020
A drug delivery perspective on intratumoral-immunotherapy in renal cell carcinomaWilson S Meng, Nicholas J Salgia, Ngoc B Pham, et al.
Vaccine|March 17, 2024
Lymphatic distribution considerations for subunit vaccine design and developmentPaul R Hartmeier, Sarah M Ostrowski, Emelia E Busch, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Advanced Drug Delivery Reviews|December 12, 2018
Advances in immunotherapy of type I diabetesQianqian Ni, Ngoc B Pham, Wilson S Meng, et al.
American Journal of Pharmaceutical Education|January 17, 2017
A Bioinformatics Practicum to Develop Student Understanding of Immunological Rejection of Protein DrugsLauren A O'Donnell, Wilson S Meng, Benjamin J Andrick, et al.
Journal of Biomaterials Science. Polymer Edition|January 31, 2007
Characterization of particles fabricated with poly(D, L-lactic-co-glycolic acid) and an ornithine-histidine peptide as carriers of oligodeoxynucleotide for delivery into primary dendritic cellsYing Zheng, Jeffrey R Kovacs, Ellen S Gawalt, et al.
Clinical Immunology (Orlando, Fla.)|March 17, 2015
Generation of antigen-specific Foxp3+ regulatory T-cells in vivo following administration of diabetes-reversing tolerogenic microspheres does not require provision of antigen in the formulationCarl Engman, Yi Wen, Wilson S Meng, et al.
Molecular Immunology|October 18, 2003
A cationic peptide consists of ornithine and histidine repeats augments gene transfer in dendritic cellsSai Prasanth Chamarthy, Jeffrey R Kovacs, Erin McClelland, et al.
Plos One|August 14, 2015
Predicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNFα Biologics: Implications for Immunogenicity of Pharmaceutical ProteinsBenjamin J Andrick, Alexandra I Schwab, Brianna Cauley, et al.
Fluids (Basel, Switzerland)|June 24, 2026
Evaluation of Flow-Induced Shear in a Porous Microfluidic Slide: CFD Analysis and Experimental InvestigationManoela Neves, Gayathri Aparnasai Reddy, Anitha Niyingenera, et al.
Biomaterials|December 19, 2007
Expansion of Foxp3-expressing regulatory T cells in vitro by dendritic cells modified with polymeric particles carrying a plasmid encoding interleukin-10Liang Jia, Jeffrey R Kovacs, Ying Zheng, et al.
Urologic Oncology|May 14, 2020
A drug delivery perspective on intratumoral-immunotherapy in renal cell carcinomaWilson S Meng, Nicholas J Salgia, Ngoc B Pham, et al.
Vaccine|March 17, 2024
Lymphatic distribution considerations for subunit vaccine design and developmentPaul R Hartmeier, Sarah M Ostrowski, Emelia E Busch, et al.
Pageof 5